BRIEF published on 05/06/2026 at 08:57, 3 days 7 hours ago Innoscripta décroche un nouveau client mondial en logistique Logistique Mondiale Crédits D'impôt Innoscripta Clusterix Plateforme De R&D
BRIEF published on 05/06/2026 at 08:57, 3 days 7 hours ago Innoscripta Secures New Global Logistics Client Global Logistics Tax Credits Innoscripta R&D Platform Clusterix
PRESS RELEASE published on 05/06/2026 at 08:52, 3 days 7 hours ago innoscripta Wins Global Logistics Player as New Client innoscripta SE secures leading global logistics company as a new client, enhancing R&D platform position in logistics sector. Contract term over three years Contract Global Logistics Logistics Sector Innoscripta SE R&D Platform
BRIEF published on 04/22/2026 at 13:00, 17 days 3 hours ago Innoscripta SE approuve un dividende de 4,00 EUR et renforce son conseil de surveillance Conseil De Surveillance Déménagement Du Siège Social Approbation Des Dividendes Marchés Des Capitaux Innoscripta SE
BRIEF published on 04/22/2026 at 13:00, 17 days 3 hours ago Innoscripta SE Approves EUR 4.00 Dividend and Strengthens Supervisory Board Headquarters Relocation Capital Markets Supervisory Board Dividend Approval Innoscripta SE
PRESS RELEASE published on 04/22/2026 at 12:55, 17 days 3 hours ago innoscripta SE: Annual General Meeting approves dividend of EUR 4.00 per share and confirms Supervisory Board with strong capital markets expertise innoscripta SE shareholders approve EUR 4.00 dividend per share at AGM and confirm Supervisory Board with capital markets expertise Dividend Capital Markets Supervisory Board AGM Innoscripta SE
BRIEF published on 04/15/2026 at 09:05, 24 days 7 hours ago Innoscripta Expands into French Market French Market European Expansion Clusterix Platform R&D Incentives Toulouse Innovation Hub
BRIEF published on 04/15/2026 at 09:05, 24 days 7 hours ago Innoscripta s'étend au marché français Expansion Européenne Marché Français Plateforme Clusterix Incitations À La R&D Pôle D'innovation De Toulouse
PRESS RELEASE published on 04/15/2026 at 09:00, 24 days 7 hours ago innoscripta drives expansion in Europe: Market entry in France completed innoscripta expands into French market through new office in Toulouse, targeting tax incentive opportunities and offering Clusterix platform for streamlined R&D management Expansion R&D France Innoscripta Clusterix
BRIEF published on 03/19/2026 at 08:55, 1 month 21 days ago Innoscripta SE Expands with New Office in Frankfurt Expansion Frankfurt Innoscripta R&D Platform Clusterix
Published on 05/09/2026 at 01:30, 15 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 16 hours 30 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 19 hours 52 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 21 hours 17 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 21 hours 28 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 21 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 21 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 21 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 21 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 21 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
